S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

OCUL Ocular Therapeutix Inc

7.68

0.04 (0.52%)

Pre Market

Last Updated: 07:33:11

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Ocular Therapeutix Charts.

Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Ocular Therapeutix Charts.

Ocular Therapeutix Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (3 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 February 2025 (3 days ago) • Edgar (US Regulatory)

Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
Monday 3 February 2025 (4 days ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Friday 31 January 2025 (7 days ago) • Edgar (US Regulatory)

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 17 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
Tuesday 14 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
Wednesday 8 January 2025 (1 month ago) • GlobeNewswire Inc.

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 13 December 2024 (2 months ago) • GlobeNewswire Inc.

Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 10 December 2024 (2 months ago) • GlobeNewswire Inc.

Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1
Monday 2 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

More Ocular Therapeutix Inc News Articles

Vontobel Financial Produ...

Intesa Sanpaolo

BNP Paribas Issuance

Vontobel Financial Produ...

Vertex Pharmac Dl 01

L&G ESG Emr Mark Cor Bon...

Societe Generale Effekten

Wisdomtree Carbon Indivi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions